Victoria's Secret & Co.: Morgan Stanley raises target price to $101 from $99
VSCO•Related News
Rein Therapeutics presents late-breaking ERS poster on inhaled LTI-03 idiopathic pulmonary fibrosis dose-escalation trial
RNTX•
Polestar files Form 3 as director Arkadiusz Nowinski reports no beneficial ownership in PSNY shares
PSNY•
S&P 500, Dow set for lower open after jobs report fuels rate-hike bets
SPY•
Leonardo DRS CFO Michael Dippold disposes of 20,317 common shares worth $755,386.06
DRS•
EdgeMode extends review talks with BlackBerry AIF, BLACK AI Group by up to six months
EDGM•